Vistin Pharma

Less than 1K followers

VISTN

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Vistin Pharma is a Norwegian pharmaceutical company. The company conducts research and development and further production of pharmaceutical substances (API), mainly the substances metformin, codeine phosphate and pholcodine. The substances are mainly used in the treatment of diabetes. The company operates on a global level, with the largest presence in the Nordic market. Vistin Pharma was founded in 2015 and is headquartered in Oslo.

Read more
Market cap
-
Turnover
-
Revenue
452.29M
EBIT %
20.42 %
P/E
-
Dividend yield-%
-
Financial calendar
20.5
2026

General meeting '26

21.5
2026

Half year dividend

20.8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.